维普中文期刊产品整合服务
377篇 您的检索式:作者名="Vokes"
    题名 作者 年代 出处 被引量
1Nasopharyngeal carcinoma显示文摘Vokes EE Liebowitz DN Weichselbaum RR 1997Lancet1997,350,:3
2CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304显示文摘Martin J. Edelman Lydia Hodgson Paula Y. Rosenblatt Robert H. Christenson Everett E. Vokes Xiaofei Wang Robert Kratzke 2012Journal of Thoracic Oncology2012,,4:3
3Characteristics of near neutral pH stress corrosion cracks in an X65 pipeline显示文摘Chen W King F Vokes E 2002Corrosion2002,58,3:2
4Randomized phase Ⅱ study of cisplatin with gemcitabin or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage ⅢB Non-small Cell Lung Cancer:cancer and leukemia group B study 9431显示文摘Vokes EE Herndon JE Crawford J 2002J Clin Oncol2002,20,:1
5Concomitant chemoradiotherapy: rationale and chnical experience in patients with solid tumors显示文摘Vokes E E Weichselbaum R R 1990Journal of Clinical Oncology1990,8,5:1
6CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304显示文摘Martin J. Edelman Lydia Hodgson Paula Y. Rosenblatt Robert H. Christenson Everett E. Vokes Xiaofei Wang Robert Kratzke 2012Journal of Thoracic Oncology2012,,4:1
7Axitinib is an active treatment for all histologic subtypes of advanced thyroid 显示文摘Cohen EE Rosen LS Vokes EE 2008Journal of Clinical Oncology2008,26,29:1
8Trends and perspectives in multimodality therapy of locoregionally advanced non-small cell lung cancer显示文摘Everett E Vokes John E 2001Lung Cancer2001,33,1:1
9Characteristics of Nearneutral-pH Stress Corrosion Cracks in an X-65 Pipeline显示文摘CHEN W KING F VOKES E 2002Corrosion2002,58,3:1
10Induction or consolidation systemic therapy in the multimodality treatment of unresectable locally advanced non-small cell lung cancer显示文摘Ready NE Vokes EE 2003Lung Cancer2003,42,1:1
11Lung cancer显示文摘Hoffman PC Mauer AM Vokes EE 0,,9202:1
12Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage ~ Non-small-cell lung canc- er:Cancer and Leukemia Group B显示文摘Vokes EE Herndon JE 2nd Kelley M J 2007J Clin Oncol2007,25,13:1
13Limited-sampling models for irinotecan pharmacokinetics-pharmacodynamics: prediction of biliary index and intestinal toxicity 显示文摘Mick R Gupta E Vokes EE 1996J Clin Oncol1996,14,7:1
14A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer 显示文摘VOKES E E ANSARI R H MASTERS G A 1998Ann Oncol1998,9,10:1
15Multi- center phase lI study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck显示文摘SOULIERES D SENZER N N VOKES E E 2004J Clin Oncol2004,22,:1
16Somnolence after prophylactic cranial irradiation in children with acute lymphoblastic leukaemia显示文摘FREEMAN J E JOHNSTON P G VOKE J M 1973Br Med J1973,1973,:1
17PROCLAIM:A phase Ⅲ study of pemetrexed,cisplatin,and radiation therapy followed by consolidation pemetrexed versus etoposide,cisplatin,and radiation therapy followed by consolidation cytotoxic chemotherapy of choice in locally advanced stage Ⅲ Non-small Cell Lung Cancer of other than predominantly squamous cell histology显示文摘Vokes EE Senan S Treat JA 2009Clin Lung Cancer2009,10,:1
18Induction chem-otherapy followed by chemoradiotherapy compared with chemora-diotherapy alone for regionally advanced unresectable stage HINon-small-cell lung cancer: Cancer and Leukemia Group B显示文摘Vokes EE Hemdon JE 2nd Kelley MJ 2007J Clin Oncol2007,25,13:1
19Randomized phase Ⅱ study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage Ⅲb non-small-cell lung cancer:cancer and leukemia group B study 9431显示文摘Vokes EE Herndon JE 2nd Crawford J 2002J Clin Oncol2002,20,:1
20Oncomitant chemotherapy rational and chnical experience in patients with solid tumors显示文摘Vokes EE Weichselbaum RR 0,,05:1
返回顶部 每页显示:
共19页 首页 上一页 第1页 下一页 末页 /19 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费